Information Library
Cost control/reduction - Enrollment & retention
To learn more about a particular aspect of Quintiles’ pharma services, biotech development or drug commercialization services, select a topic at left. If you’ve already specified a choice, you may narrow your search by selecting additional categories in any order. For example, for information on oncology drug development, start by selecting oncology. Then you can narrow your search to Central Lab, News Releases and Europe.
- Sort by: Most Recent
- Title
-
Sub-Saharan Africa Phase II/III Fact Sheet
July 29, 2009
Sub-Saharan Africa fact sheet about Phase II/III trials. The gateway to Africa: Access to expanded clinical resources and patient populations in South Africa and beyond. -
Phase One Services: Professor Anders E. Grahnen
July 24, 2009
With the current high costs of drug development, it's crucial that you can establish the potential success of your agent before the end of Phase II. Our market-leading expertise in biomarkers and specialist techniques can help you do just that. -
Call Centers with a Global Reach
March 31, 2009
Call center services provided globally. -
Antibiotic Safety Assessment
March 25, 2009
A major pharmaceutical company presented Quintiles with a pressing challenge – to collect extensive amounts of Phase IV data in compressed time windows because the treatment conditions were subject to seasonal variants.
Page 1 of 1 (4 items)